XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.2
GOODWILL AND OTHER INTANGIBLE ASSETS
 6 Months Ended
Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL AND OTHER INTANGIBLE ASSETS
Changes in the carrying amount of goodwill for our reportable segments for the six months ended June 30, 2023 were as follows:
InsuranceCenterWellTotal
 (in millions)
Balance at January 1, 2023$2,472 $6,670 $9,142 
Acquisitions191 206 397 
Balance at June 30, 2023$2,663 $6,876 $9,539 
The following table presents details of our other intangible assets included in other long-term assets in the accompanying condensed consolidated balance sheets at June 30, 2023 and December 31, 2022:
 June 30, 2023December 31, 2022
Weighted
Average
Life		CostAccumulated
Amortization		NetCostAccumulated
Amortization		Net
 ($ in millions)
Other intangible assets:
Certificates of needIndefinite$1,132 $— $1,132 $1,132 $— $1,132 
Medicare licensesIndefinite302 — 302 286 — 286 
Customer contracts/
    relationships		9.4 years955 696 259 929 673 256 
Trade names and
    technology		6.7 years139 103 36 142 107 35 
Provider contracts11.6 years73 64 9 73 63 10 
Noncompetes and
    other		8.4 years84 40 44 86 40 46 
Total other intangible
    assets		9.2 years$2,685 $903 $1,782 $2,648 $883 $1,765 
    For the three months ended June 30, 2023 and 2022, amortization expense for other intangible assets was approximately $16 million and $18 million, respectively. For the six months ended June 30, 2023 and 2022, amortization expense for other intangible assets was approximately $34 million and $36 million, respectively. The following table presents our estimate of amortization expense remaining for 2023 and each of the five next succeeding years at June 30, 2023:
 (in millions)
For the years ending December 31,
2023$32 
202460 
202558 
202644 
202734 
202829 
For additional information regarding our goodwill and intangible assets, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2022 Form 10-K.